Status:
COMPLETED
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
Lead Sponsor:
Chapman University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Stroke
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
People post-stroke retain the capacity to modify walking patterns explicitly using biofeedback and implicitly when encountering changes in the walking environment. This proposal will assess changes in...
Detailed Description
This proposal aims to determine the effects of explicitly driven or implicitly driven walking modifications on muscle activation patterns and co-contraction post-stroke. This work is significant, as s...
Eligibility Criteria
Inclusion
- Inclusion Criteria for stroke survivors are:
- Chronic hemiparesis (time since stroke \> 6 months) caused by a single documented stroke event.
- Ability to walk on the treadmill continuously for 2 minutes
- Ability to walk over ground independently or with the use of a cane
- No concurrent neurological disorders or orthopedic conditions that interfere with their ability to walk
- No prior experience walking on a split-belt treadmill
- Normal or corrected to normal vision
- The ability for them or a guardian to provide informed consent.
- Inclusion criteria for neurotypical adults are:
- No musculoskeletal conditions or injuries that limit walking ability within the last two years
- No history of neurological disorders or severe head trauma
- No prior experience walking on a split-belt treadmill
- Normal or corrected to normal vision.
- Exclusion Criteria for stroke survivors are:
- Inability to walk
- Concurrent neurological disorders or orthopedic conditions that interfere with their ability to walk
- More than one stroke
- Visual neglect
- Uncontrolled hypertension
- Inability to provide informed consent.
- Exclusion Criteria for neurotypical controls are:
- Inability to walk
- Concurrent neurological disorders or orthopedic conditions that interfere with their ability to walk
- Uncontrolled hypertension
- Inability to provide informed consent.
Exclusion
Key Trial Info
Start Date :
September 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06034119
Start Date
September 7 2023
End Date
June 30 2025
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chapman University
Irvine, California, United States, 92618